Abstract
Introduction
The adenomatous polyposis coli (APC) gene is a tumor suppressor gene that is inactivated in the initiation of colorectal neoplasia. Apc Min/+ mice, which possess a heterozygous APC mutation, develop numerous adenomatous polyps, which are similar to those observed in familial adenomatous polyposis (FAP) in humans. However, unlike FAP patients, Apc Min/+ mice predominantly develop adenomatous polyps in the small intestine. The metabolic changes associated with the development of polyps in the small and large intestine remain to be investigated.
Objectives
The objective of this study was to elucidate the metabolic changes associated with intestinal polyp formation.
Methods
We compared the metabolite levels of pairs of polyp and non-polyp tissues obtained from the small intestines (n = 12) or large intestines (n = 7) of Apc Min/+ mice. To do this, we analyzed the tissue samples using two methods, liquid chromatography-tandem mass spectrometry (1) with a pentafluorophenylpropyl column for cation analysis, and (2) with a C18 reversed phase column coupled to an ion-pair reagent for anion analysis.
Results
Pathway mapping of the metabolites whose levels were significantly altered revealed that the polyp tissue of the small intestine contained significantly higher levels of intermediates involved in glycolysis, the pentose phosphate pathway, nucleotide metabolism, or glutathione biosynthesis than in the equivalent non-polyp tissue. In addition, significantly higher levels of methionine cycle intermediates were detected in the polyp tissues of both the large and small intestines. Organ-dependent (small vs. large intestine) differences were also detected in the levels of most amino acids and urea cycle intermediates.
Conclusion
Our results indicate that various metabolic changes are associated with polyp development, and understanding these alterations could make it possible to evaluate the treatment response of colorectal cancer earlier.
Similar content being viewed by others
References
Alonso-Aperte, E., González, M. P., Póo-Prieto, R., & Varela-Moreiras, G. (2008). Folate status and S-adenosylmethionine/S-adenosylhomocysteine ratio in colorectal adenocarcinoma in humans. European Journal of Clinical Nutrition, 62, 295–298.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993). Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences of the United States of America, 90, 7915–7922.
Chowdhury, S. K. R., Gemin, A., & Singh, G. (2005). High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochemical and Biophysical Research Communications, 333, 1139–1145.
Corpet, D. E., & Pierre, F. (2003). Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiology Biomarkers and Prevention, 12, 391–400.
Cumbiner, B. M. (1995). Signal transduction by β-catenin. Current Opinion in Cell Biology, 7, 634–640.
Ellis, D. I., & Goodacre, R. (2006). Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. The Analyst, 131, 875–885.
Finkelstein, J. D. (1990). Methionine metabolism in mammals. The Journal of Nutritional Biochemistry, 1, 228–237.
Frederiks, W. M., Vizan, P., Bosch, K. S., Vreeling-Sindelárová, H., Boren, J., & Cascante, M. (2008). Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre)neoplastic lesions in rat liver. International Journal of Experimental Pathology, 89, 232–240.
Gerner, E. W., & Meyskens, F. L. (2004). Polyamines and cancer: old molecules, new understanding. Nature Reviews Cancer, 4, 781–792.
Hirayama, A., Kami, K., Sugimoto, M., et al. (2009). Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Research, 69, 4918–4925.
Ikeda, K., Mutoh, M., Teraoka, N., Nakanishi, H., Wakabayashi, K., & Taguchi, R. (2011). Increase of oxidant-related triglycerides and phosphatidylcholines in serum and small intestinal mucosa during development of intestinal polyp formation in Min mice. Cancer Science, 102, 79–87.
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012). KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Research, 40, 109–114.
Linder, N., Martelin, E., Lundin, M., et al. (2009). Xanthine oxidoreductase—Clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells. European Journal of Cancer, 45, 648–655.
Lu, S. C. (2012). Glutathione synthesis. Biochimica et Biophysica Acta, 1830, 3143–3153.
MacDonald, M. J., Warner, T. F., & Mertz, R. J. (1990). High activity of mitochondrial glycerol phosphate dehydrogenase in insulinomas and carcinoid and other tumors of the amine precursor uptake decarboxylation system. Cancer Research, 50, 7203–7205.
Mashego, M. R., Rumbold, K., De Mey, M., Vandamme, E., Soetaert, W., & Heijnen, J. J. (2007). Microbial metabolomics: Past, present and future methodologies. Biotechnology Letters, 29, 1–16.
Miller, D. M., Thomas, S. D., Islam, A., Muench, D., & Sedoris, K. (2012). c-Myc and cancer metabolism. Clinical Cancer Research, 18, 5546–5553.
Mráček, T., Drahota, Z., & Houštěk, J. (2013). The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues. Biochimica et Biophysica Acta, 1827, 401–410.
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). “Metabonomics”: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29, 1181–1189.
Pasikanti, K. K., Ho, P. C., & Chan, E. C. Y. (2008). Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. Journal of Chromatography B, 871, 202–211.
Phan, L. M., Yeung, S. C. J., & Lee, M. H. (2014). Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biology and Medicine, 11, 1–19.
Saito, K. (2013). Phytochemical genomics-a new trend. Current Opinion in Plant Biology, 16, 373–380.
Sansom, O. J., Meniel, V. S., Muncan, V., et al. (2007). Myc deletion rescues Apc deficiency in the small intestine. Nature, 446, 676–679.
Sato, K., Tsuchihara, K., Fujii, S., et al. (2007). Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Research, 67, 9677–9684.
Soga, T., Ohashi, Y., Ueno, Y., Naraoka, H., Tomita, M., & Nishioka, T. (2003). Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. Journal of Proteome Research, 2, 488–494.
Spratlin, J. L., Serkova, N. J., & Eckhardt, S. G. (2009). Clinical applications of metabolomics in oncology: A review. Clinical Cancer Research, 15, 431–440.
Steward, W. P., & Brown, K. (2013). Cancer chemoprevention: a rapidly evolving field. British Journal of Cancer, 109, 1–7.
Taketo, M. M., & Edelmann, W. (2009). Mouse models of colon cancer. Gastroenterology, 136, 780–798.
Theodoridis, G., Gika, H. G., & Wilson, I. D. (2008). LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. Trends in Analytical Chemistry, 27, 251–260.
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-tieulent, J., & Jemal, A. (2015). Global Cancer Statistics, 2012. Cancer Journal for Clinicians, 65, 87–108.
Urakami, K., Zangiacomi, V., Yamaguchi, K., & Kusuhara, M. (2013). Impact of 2-deoxy-d-glucose on the target metabolome profile of a human endometrial cancer cell line. Biomedical Research, 34, 221–229.
Winawer, S., Fletcher, R., Rex, D., et al. (2003). Colorectal cancer screening and surveillance: Clinical guidelines and rationale—Update based on new evidence. Gastroenterology, 124, 544–560.
Wishart, D. S. (2008). Metabolomics: applications to food science and nutrition research. Trends in Food Science and Technology, 19, 482–493.
Yoshie, T., Nishiumi, S., Izumi, Y., et al. (2012). Regulation of the metabolite profile by an APC gene mutation in colorectal cancer. Cancer Science, 103, 1010–1021.
Acknowledgments
This study was supported in part by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [M.Y.]; a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [S.N.]; and AMED-CREST from the Agency for Medical Research and Development [M.Y.].
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest in the submission of this manuscript.
Ethical statement
All institutional, national, and international ethical guidelines for the care and use of laboratory animals were followed.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Suzuki, M., Nishiumi, S., Kobayashi, T. et al. LC–MS/MS-based metabolome analysis detected changes in the metabolic profiles of small and large intestinal adenomatous polyps in Apc Min/+ mice. Metabolomics 12, 68 (2016). https://doi.org/10.1007/s11306-016-0988-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-016-0988-7